Merck's at-home antiviral COVID-19 pill gets U.S. authorisation

Molnupiravir was shown to reduce hospitalisations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness

from The Hindu - International https://ift.tt/3mtqStv